Skip to content

Ophtala

Active Private limited companyfounded 2018active for 8 yearsManoir d'Anjoulaan 42, 1150 Woluwe-Saint-PierreKBO/BCE: BE 0695.489.307

Lifetime

8 annual accounts with figures on one time axis
peak of €349,456 in 2021
€307,474▼ 4.9%
peak of €178,070 in 2021
€163,150▲ 25.5%
peak of €248,952 in 2022
€74,610▲ 265%
€435,078▲ 72.8%
Board1 name since 2018
1 director
Documentsfilings and deeds
21-09-202652 days late
2025micro format
Result from €129,950 to €163,150Dividend €109,000Equity from €20,460 to €74,610Debts from €251,797 to €435,078Investments €403,893Cash from €93,073 to €29,894

Key points

from the 2025 annual accounts

Equity

€74,610 ▲ 265%
€20,5002024€74,6002025

Equity rose in 2025 from €20,460 to €74,610.

Debts

€435,078 85% of the balance sheet
Financial debts 50%Suppliers 20%Taxes and wages 23%Other 8%

Of this, €218,113 falls due within a year.

Investments

€421,443 12.9 times depreciation
20212022202320242025

Green is investment, beige is depreciation. Land and buildings stand 2225.5% higher than in 2024.

Liquidity

0.22 was 0.72 in 2024

Short-term debts fell from €251,797 to €218,113.

Filings

8 annual accounts 8 late
AprilJune31 JulyOctober20202025

The 2018 accounts came in latest, 217 days after the end of the period.

Position in the sector

14.6%

Lower solvency than 83% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,684 companies had the same profile as Ophtala has now. Each dot stands for 7 companies, two years later.

97.2%
were still trading
1.3%
stopped another way
1.3%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,684 companies, not a prediction for Ophtala. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 30-04-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0695489307
Amendment of the articles · Legal-form change · Resignations & appointments appointed as sole director · Discharge granted to · General meeting of 22-12-2023 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares · Founded by · appointed as manager · published on 30-04-2018 · Gazette deed
First establishment CABINET MANOIR D'ANJOU, Manoir d'Anjoulaan 42, Woluwe-Saint-Pierre
All 15 events

Comparable companies

same main activity, similar in size and age
Company
Ophtala Woluwe-Saint-Pierre €509,688 €307,474 14.6% -
Rhino médical Uccle €540,626 €311,351 92.6% -
DOKTER VALERIE VERMEERSCH Ghent €490,546 €324,211 45.7% -
Dr. Brozici Pneumoloog Mol €505,906 €314,202 49.5% -
Dr. Griet Buyck, Geriater Bruges €478,767 €300,649 82.1% -
Dr. Luc Walschot Mechelen €459,376 €314,477 54.3% -
Dokter Vermeersch Joachim, Urgentiegeneeskunde Dendermonde €516,288 €283,779 35.7% -

These companies have the same main activity as Ophtala: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €459,000 and €541,000, founded between 2017 and 2019.

Official details

Source: KBO
Status
Active since 26-04-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.280.557.9911150 Woluwe-Saint-Pierre, since 26-04-2018
Financial year end
31 December
Peppol
Reachable since 19-12-2025
Company details

Annual accounts 2025

≈ €460,000estimated
€509,688▲ 87.2%
Filing
Filed on 21-09-2026
Financials

Insights on Ophtala

Ophtala files the micro format. That format states no turnover. The gross margin rose from €146,898 in 2018 to €307,474 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Ophtala

What is the company number of Ophtala?
The company number of Ophtala is 0695.489.307. The VAT number is the same number with BE in front: BE 0695.489.307.
Where is Ophtala based?
The registered office is at Manoir d'Anjoulaan 42, 1150 Woluwe-Saint-Pierre.Company details
What does Ophtala do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Ophtala?
Ophtala is a private limited company (BV).
When was Ophtala founded?
Ophtala was founded on 26-04-2018.
Is Ophtala still active?
Yes, Ophtala is an active enterprise in the KBO register.
What is the turnover of Ophtala?
The turnover in financial year 2025 is about €460,000. This figure is estimated from the gross margin of €307,474 and 31 comparable companies (NACE 86220). It probably lies between €410,000 and €640,000.Financials
Is Ophtala profitable?
In financial year 2025, Ophtala made a profit of €163,150.
Where can I find the annual accounts of Ophtala?
Ophtala filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Ophtala due?
Ophtala must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.